Sparks JA, Wallace ZS, Seet AM, Robinson PC, et al. Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by Sparks et al. Ann Rheum Dis 2021 Aug 13. pii: annrheumdis-2021-221157.
PMID: 34389604